Egg allergy is defined as an allergic reaction induced due to immunological nature of egg proteins. The condition includes other allergic syndromes as well such as atopic dermatitis and eosinophilic esophagitis. It is estimated that Egg Allergy Market is expected to grow at a CAGR 6.5% during the forecast period of 2017-2023. Egg allergy is more prevalent in children and can outgrow before adolescence. There are majorly five allergenic proteins present in the egg of a chicken. Most allergenic egg proteins found in egg white are ovomucoid (Gal d 1), ovalbumin (Gal d 2), lysozyme (Gal d 4), and ovotransferrin (Gal d 3). Ovalbumin (OVA) is the most abundant protein and ovomucoid (OVM) is the dominant allergen in egg. It is also found that vaccines such as, Measles-mumps-rubella (MMR) vaccines, Yellow fever vaccine, and Flu (influenza) vaccines, also triggers an allergic reaction as they are developed from an egg.
Increasing prevalence of egg allergy, consumer awareness and improved allergy diagnosis, increasing incidences of asthma, and increasing incidences of asthma promote the growth of egg allergy market. As per the study published in Pediatric Clinics of North America journal in 2014, the prevalence rate of egg allergy in German children is 0.0004%, 0.6% in children from Mexico, and 1.6% in Danish children. In the United States, 1.3% of prevalence rate was reported.
Key Players: Genentech, Inc., Novartis AG., Pfizer Inc., Sun Pharmaceutical Industries Ltd., Bayer AG, Abbott, Astellas, Sanofi, Merck & Co., Inc., Creative Diagnostic Medicare Pvt. Ltd., and ImmuneTech.
Get Sample Copy @ https://www.marketresearchfuture.com/sample_request/4734 .
The Americas dominate the egg allergy market owing to the increasing consumer awareness among people, and high healthcare expenditure. According to the study published in the JAMA Pediatrics journal in 2013, the overall cost incurred by the food allergy in the United States was nearly USD 25 billion annually.
Europe holds the second position in an egg allergy market. It is found that increasing incidence of egg allergy due to egg protein will drive the market in Europe region.
Asia Pacific represents the fastest growing egg allergy market owing to the increasing innovation in allergen-free food products, and increasing per capita spending on healthcare.
The egg allergy market is segmented on the basis of diagnosis, treatment & management and end-users.
On the basis of diagnosis, market is segmented into skin-prick test, atopy patch test (APT), blood test, oral food challenge, and others.
On the basis of treatment & management, market is classified into Oral Immunotherapy (OIT), Medication, and others. Medication is further segmented into antihistamins, epinephrine shots, and others.
On the basis of end-users, market is segmented into hospital & clinics, diagnostic centers, research & academic institutes, and others.
TABLE OF CONTENT
Chapter 1. Report Prologue
Chapter 2. Market Introduction
Chapter 3. Research Methodology
Chapter 4. Market Dynamics
Chapter 5. Market Factor Analysis
Chapter 6. Global Egg Allergy Market, By Diagnosis
Chapter 7. Global Egg Allergy Market, By Treatment & Management
Chapter 8 Global Egg Allergy Market, By End User
Chapter 9. Global Egg Allergy Market, By Region
Chapter 10 Company Landscape
Chapter 11 Company Profiles
Chapter 12 MRFR Conclusion
Ask Question to Expert @ https://www.marketresearchfuture.com/enquiry/4734 .
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Market Research Future
+1 646 845 9312
Company Name: Market Research Future
Contact Person: Akash Anand
Phone: +1 646 845 9312
Address:Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar, Pune –